Trials / Completed
CompletedNCT01912053
Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma
An Open-label, Multicenter, Phase II Trial, to Evaluate the Efficacy of Intra-hepatic Administration of Yttrium 90-labelled Microspheres (Therasphere®, Nordion) in Association With Intravenous Chemotherapy With Gemcitabine and Cisplatin for the Treatment of Intra-hepatic Cholangiocarcinoma, First Line.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Center Eugene Marquis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess efficacy and tolerance of intra-hepatic administration of Yttrium 90-labelled microsphere (Theraspheres®, Nordion) in association with intravenous chemotherapy with Gemcitabin and Cisplatin for the treatment of intra-hepatic cholangiocarcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Therasphere® in association with Gemcitabine and Cisplatin | Therasphere® is a radioelement |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2016-12-01
- Completion
- 2017-11-01
- First posted
- 2013-07-30
- Last updated
- 2018-05-11
Locations
7 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01912053. Inclusion in this directory is not an endorsement.